Brief: Starpharma To Receive A$6.5M From Mundipharma And Vivagel BV Rights
Aug 14 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* TO RECEIVE A$6.5M FROM MUNDIPHARMA AND VIVAGEL BV RIGHTS
* WILL TERMINATE ITS VIVAGE BV LICENCE AND SUPPLY AGREEMENTS
WITH
MUNDIPHARMA
* WELL POSITIONED TO SIGN NEW COMMERCIAL ARRANGEMENTS FOR
VIVAGEL
BV WITH OTHER HEALTHCARE COMPANIES
Source text for Eikon: ID:nASX2Lsl1y
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising